Lv11
46 积分 2024-06-17 加入
Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment
9小时前
待确认
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
3天前
已完结
The safety, tolerability, pharmacokinetics and pharmacodynamics of an optimized dual GLP‐1/GIP receptor agonist (BGM0504) in healthy volunteers: A dose‐escalation Phase I study
18天前
已完结
Sarcopenic obesity in older adults: a clinical overview
2个月前
已完结
Hypothalamic obesity: from basic mechanisms to clinical perspectives
2个月前
已完结
Metabolic dysfunction-associated steatotic liver disease in adults
2个月前
已完结
Definition and diagnostic criteria of clinical obesity
5个月前
已完结
[Epidemiology and prediction of overweight and obesity among children and adolescents aged 7-18 years in China from 1985 to 2019]
5个月前
已完结
[Developmental characteristics on body composition in Chinese urban children and adolescents aged 3-17 years old]
5个月前
已完结
Cardiovascular, Kidney and Safety Outcomes with GLP-1 Receptor Agonists Alone and in Combination with SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis
8个月前
已完结
皖公网安备34019202002308
